Critical Role for the Chemokine Receptor CXCR6 in Homeostasis and Activation of CD1d-Restricted NKT Cells1

NK T (NKT) cells play important roles in the regulation of diverse immune responses. However, little is known about the mechanisms that regulate homeostasis and activation of these cells. Thymic NKT cells up-regulated the chemokine receptor CXCR6 following positive selection and migrated toward CXCL16 in vitro. However, CXCR6 was not essential for thymic development or maturation. In contrast, liver and lung NKT cells were depleted in CXCR6+/− and CXCR6−/− mice. The reduction in liver and lung NKT cells coincided with an increase in bone marrow NKT cells, suggesting a redistribution of NKT cells in CXCR6−/− animals. In wild-type mice, CXCL16 neutralization reduced accumulation of mature NK1.1+, but not immature NK1.1− NKT cell recent thymic emigrants in the liver. Given that thymic NKT cells are preferentially exported as NK1.1− cells, this suggests an additional role for CXCR6/CXCL16 in maturation or survival of immature liver NKT cells. CXCL16 blockade did not deplete resident NK1.1+ NKT cells, indicating that CXCR6/CXCL16 are not required to retain mature NKT cells in the liver. Cytokine production by liver and spleen NKT cells was impaired in CXCR6−/− mice following in vivo stimulation with α-galactosylceramide, implicating a novel role for CXCR6 in NKT cell activation. Reduced IFN-γ production was not due to an intrinsic defect as production was normal following PMA and ionomycin stimulation. Preformed transcripts for IL-4, but not IFN-γ, were reduced in CXCR6−/− liver NKT cells. These data identify critical roles for CXCR6/CXCL16 in NKT cell activation and the regulation of NKT cell homeostasis.

[1]  M. Suematsu,et al.  Critical Role for CXC Chemokine Ligand 16 (SR-PSOX) in Th1 Response Mediated by NKT Cells1 , 2007, The Journal of Immunology.

[2]  G. Besra,et al.  Peripheral NK1.1− NKT Cells Are Mature and Functionally Distinct from Their Thymic Counterparts1 , 2007, The Journal of Immunology.

[3]  James J. Campbell,et al.  iNKT Cells Require CCR4 to Localize to the Airways and to Induce Airway Hyperreactivity1 , 2007, The Journal of Immunology.

[4]  M. Kronenberg,et al.  The unique role of natural killer T cells in the response to microorganisms , 2007, Nature Reviews Microbiology.

[5]  J. Stein‐Streilein,et al.  Invariant NKT Cells and Tolerance , 2007, International reviews of immunology.

[6]  M. Krummel,et al.  Surface-bound chemokines capture and prime T cells for synapse formation , 2006, Nature Immunology.

[7]  A. Viola,et al.  T cells and their partners: The chemokine dating agency. , 2006, Trends in immunology.

[8]  T. Fujisawa,et al.  Natural killer T cell‐mediated antitumor immune responses and their clinical applications , 2006, Cancer science.

[9]  R. Steinman,et al.  Glycolipid α-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice , 2006 .

[10]  M. Smyth,et al.  Long-Term Retention of Mature NK1.1+ NKT Cells in the Thymus1 , 2006, The Journal of Immunology.

[11]  B. Beghé,et al.  Role for CXCR6 and its ligand CXCL16 in the pathogenesis of T-cell alveolitis in sarcoidosis. , 2005, American journal of respiratory and critical care medicine.

[12]  D. Pellicci,et al.  Differential antitumor immunity mediated by NKT cell subsets in vivo , 2005, The Journal of experimental medicine.

[13]  N. Miyasaka,et al.  Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis. , 2005, Arthritis and rheumatism.

[14]  D. Wei,et al.  Characterization of the early stages of thymic NKT cell development , 2005, The Journal of experimental medicine.

[15]  N. Ohkohchi,et al.  Cutting Edge: Critical Role of CXCL16/CXCR6 in NKT Cell Trafficking in Allograft Tolerance 1 , 2005, The Journal of Immunology.

[16]  D. Wei,et al.  Expansion and long-range differentiation of the NKT cell lineage in mice expressing CD1d exclusively on cortical thymocytes , 2005, The Journal of experimental medicine.

[17]  Lisa M. Ebert,et al.  Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues. , 2005, Molecular immunology.

[18]  Mitchell Kronenberg,et al.  Intravascular Immune Surveillance by CXCR6+ NKT Cells Patrolling Liver Sinusoids , 2005, PLoS biology.

[19]  E. Butcher,et al.  Role for CXCR6 in Recruitment of Activated CD8+ Lymphocytes to Inflamed Liver1 , 2005, The Journal of Immunology.

[20]  A. Ploss,et al.  Development of CD1d‐restricted NKT cells in the mouse thymus , 2004, European journal of immunology.

[21]  J. Penninger,et al.  Essential Role of LFA-1 in Activating Th2-Like Responses by α-Galactosylceramide-Activated NKT Cells1 , 2004, The Journal of Immunology.

[22]  S. Sakoda,et al.  Critical Roles of CXC Chemokine Ligand 16/Scavenger Receptor that Binds Phosphatidylserine and Oxidized Lipoprotein in the Pathogenesis of Both Acute and Adoptive Transfer Experimental Autoimmune Encephalomyelitis1 , 2004, The Journal of Immunology.

[23]  L. Kaer,et al.  NKT cells: what's in a name? , 2004, Nature Reviews Immunology.

[24]  M. Smyth,et al.  Glycolipid Antigen Drives Rapid Expansion and Sustained Cytokine Production by NK T Cells 1 , 2003, The Journal of Immunology.

[25]  Mitchell Kronenberg,et al.  Constitutive Cytokine mRNAs Mark Natural Killer (NK) and NK T Cells Poised for Rapid Effector Function , 2003, The Journal of experimental medicine.

[26]  E. Butcher,et al.  Differential Chemokine Responses and Homing Patterns of Murine TCRαβ NKT Cell Subsets 1 , 2003, The Journal of Immunology.

[27]  E. Butcher,et al.  Chemokines in the systemic organization of immunity , 2003, Immunological reviews.

[28]  J. Strominger,et al.  CD1d-Restricted NKT Cells Express a Chemokine Receptor Profile Indicative of Th1-Type Inflammatory Homing Cells 1 , 2003, The Journal of Immunology.

[29]  G. Forni,et al.  α-Galactosylceramide (KRN7000) suppression of chemical- and oncogene-dependent carcinogenesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[30]  R. Locksley,et al.  Mouse Vα14i natural killer T cells are resistant to cytokine polarization in vivo , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[31]  E. Kunkel,et al.  A Common Mucosal Chemokine (Mucosae-Associated Epithelial Chemokine/CCL28) Selectively Attracts IgA Plasmablasts 1 , 2003, The Journal of Immunology.

[32]  R. Steinman,et al.  Prolonged IFN-γ–producing NKT response induced with α-galactosylceramide–loaded DCs , 2002, Nature Immunology.

[33]  E. Butcher,et al.  Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among Vα24+Vβ11+ NKT cell subsets with distinct cytokine-producing capacity , 2002 .

[34]  E. Butcher,et al.  Chemokines in rapid leukocyte adhesion triggering and migration. , 2002, Seminars in immunology.

[35]  D. Pellicci,et al.  A Natural Killer T (NKT) Cell Developmental Pathway Involving a Thymus-dependent NK1.1−CD4+ CD1d-dependent Precursor Stage , 2002, The Journal of experimental medicine.

[36]  L. Teyton,et al.  A Thymic Precursor to the NK T Cell Lineage , 2002, Science.

[37]  I. Maričić,et al.  Activation of Natural Killer T Cells Potentiates or Prevents Experimental Autoimmune Encephalomyelitis , 2001, The Journal of experimental medicine.

[38]  L. Zitvogel,et al.  Dendritic Cell Maturation Overrules H-2d–Mediated Natural Killer T (Nkt) Cell Inhibition , 2001, The Journal of experimental medicine.

[39]  T. Yamamura,et al.  A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells , 2001, Nature.

[40]  M. Kronenberg,et al.  NKT cells derive from double-positive thymocytes that are positively selected by CD1d , 2001, Nature Immunology.

[41]  M. Kronenberg,et al.  Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes , 2001, Nature Medicine.

[42]  F. Leithäuser,et al.  Activating Immunity in the Liver. I. Liver Dendritic Cells (but Not Hepatocytes) Are Potent Activators of IFN-γ Release by Liver NKT Cells1 , 2001, The Journal of Immunology.

[43]  I. Saiki,et al.  Differential Regulation of Th1 and Th2 Functions of NKT Cells by CD28 and CD40 Costimulatory Pathways1 , 2001, The Journal of Immunology.

[44]  D. Soler,et al.  Expression Cloning of the STRL33/BONZO/TYMSTR Ligand Reveals Elements of CC, CXC, and CX3C Chemokines , 2001, The Journal of Immunology.

[45]  E. Kunkel,et al.  Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential. , 2001, The Journal of clinical investigation.

[46]  M. Smyth,et al.  NKT cells: facts, functions and fallacies. , 2000, Immunology today.

[47]  Sharon Engel,et al.  A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo , 2000, Nature Immunology.

[48]  E. Butcher,et al.  The Primate Lentiviral Receptor Bonzo/STRL33 Is Coordinately Regulated with CCR5 and Its Expression Pattern Is Conserved Between Human and Mouse1 , 2000, The Journal of Immunology.

[49]  M. Kronenberg,et al.  Tracking the Response of Natural Killer T Cells to a Glycolipid Antigen Using Cd1d Tetramers , 2000, The Journal of experimental medicine.

[50]  S. Snapper,et al.  Activation of natural killer T cells by alpha-galactosylceramide in the presence of CD1d provides protection against colitis in mice. , 2000, Gastroenterology.

[51]  L. Teyton,et al.  In Vivo Identification of Glycolipid Antigen–Specific T Cells Using Fluorescent Cd1d Tetramers , 2000, The Journal of experimental medicine.

[52]  D. Raulet,et al.  NK1.1+ T Cells in the Liver Arise in the Thymus and Are Selected by Interactions with Class I Molecules on CD4+CD8+ Cells1 , 2000, The Journal of Immunology.

[53]  M. Taniguchi,et al.  Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with alpha-galactosylceramide. , 1999, Journal of immunology.

[54]  A. Ohta,et al.  The Natural Killer T (NKT) Cell Ligand α-Galactosylceramide Demonstrates Its Immunopotentiating Effect by Inducing Interleukin (IL)-12 Production by Dendritic Cells and IL-12 Receptor Expression on NKT Cells , 1999, The Journal of experimental medicine.

[55]  E. Butcher,et al.  6-C-kine (SLC), a Lymphocyte Adhesion-triggering Chemokine Expressed by High Endothelium, Is an Agonist for the MIP-3β Receptor CCR7 , 1998, The Journal of cell biology.

[56]  Y. Tanaka,et al.  Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[57]  T. Ohteki,et al.  Lack of directed Vα14‐Jα281 rearrangements in NK1+ T cells , 1997 .

[58]  O. Lantz,et al.  An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans , 1994, The Journal of experimental medicine.

[59]  A. Lanzavecchia,et al.  An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells , 1994, The Journal of experimental medicine.

[60]  T. Pruett Cutting Edge: Critical Role of CXCL16/CXCR6 in NKT Cell Trafficking in Allograft Tolerance , 2006 .

[61]  Mitchell Kronenberg,et al.  Toward an understanding of NKT cell biology: progress and paradoxes. , 2005, Annual review of immunology.

[62]  L. Kaer α-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles , 2005, Nature Reviews Immunology.

[63]  千葉 麻子 Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of α-galactosylceramide , 2004 .

[64]  H. Hashimoto,et al.  Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of alpha-galactosylceramide. , 2004, Arthritis and rheumatism.

[65]  Albert Bendelac,et al.  An Invariant T Cell Receptor ~x Chain Is Used by a Unique Subset of Major Histocompatibility Complex Class I-specific Cd4 + and Cd4-8-t Cells in Mice and Humans , 1994 .